OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

• Market Cap: ¥12.86B
• Dividend Yield: 3.79%
• Average Volume (3M): 8.13K
• Price to Earnings (P/E): 9.5
• Beta (1Y): 0.34
• Revenue Growth: 3.95%
• EPS Growth: -11.14%
• Country: JP
• Employees: 1,354
• Sector: Healthcare
• Sector Strength: 55
• Industry: Medical - Distribution
• EPS (TTM): 48.04
• Shares Outstanding: 6,250,000
• 10 Day Avg. Volume: 7,700
• 30 Day Avg. Volume: 8,133
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 72 Outperform
• Price Target: ¥2,321.00 ▲(9.84%Upside)

OLBA HEALTHCARE HOLDINGS scores well in valuation due to its low P/E ratio and strong dividend yield, making it attractive for value investors. Financial performance is robust, with solid revenue growth and margins, though cash flow issues need addressing. Technical analysis shows a neutral trend, lacking strong momentum.

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc. (2689) is a prominent player in the healthcare sector, primarily engaged in the provision of comprehensive healthcare services and products. The company operates through a network of hospitals, clinics, and specialized medical facilities, delivering a wide range of medical and healthcare solutions. Its core offerings include inpatient and outpatient services, diagnostic services, and specialized healthcare treatments.

How the Company Makes Money

OLBA HEALTHCARE HOLDINGS, Inc. generates revenue through various streams, primarily driven by its extensive healthcare services. The company earns a significant portion of its income from providing inpatient and outpatient medical services, which include surgeries, treatments, and consultations. Revenue is also derived from diagnostic services such as imaging and laboratory testing. Additionally, OLBA HEALTHCARE holds strategic partnerships with insurance companies, facilitating a steady flow of insured patients, and collaborates with pharmaceutical companies for the supply of medications and medical devices, further enhancing its revenue streams.

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
118.56B	110.47B	107.96B	112.98B	107.90B
	Gross Profit
13.60B	12.95B	12.50B	11.60B	11.07B
	EBIT
2.23B	2.15B	2.07B	1.54B	927.03M
	EBITDA
2.83B	2.68B	2.56B	1.94B	1.16B
	Net Income Common Stockholders
1.50B	1.41B	1.54B	989.37M	326.41M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.73B	2.40B	3.19B	2.16B	1.93B
	Total Assets
43.24B	40.88B	39.97B	36.56B	33.68B
	Total Debt
1.63B	1.92B	1.28B	1.96B	3.91B
	Net Debt
-1.10B	-478.81M	-1.91B	-198.43M	1.99B
	Total Liabilities
31.86B	30.55B	30.88B	28.43B	26.40B
	Stockholders Equity
11.37B	10.33B	9.09B	8.13B	7.28B
Cash Flow		Free Cash Flow
1.61B	-910.52M	1.97B	2.49B	407.07M
	Operating Cash Flow
2.08B	-659.52M	2.42B	3.13B	862.56M
	Investing Cash Flow
-673.03M	-306.25M	-211.81M	-630.38M	-496.04M
	Financing Cash Flow
-1.09B	175.94M	-1.17B	-2.26B	439.89M

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2113.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Positive. The current price of 2113 is above the 20-day moving average (MA) of 2095.10, above the 50-day MA of 2102.38, and above the 200-day MA of 2025.24, indicating a bullish trend. The MACD of 8.65 indicates Negative momentum. The RSI at 51.14 is Neutral, neither overbought nor oversold. The STOCH value of 66.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3417	80 Outperform	¥14.30B	5.36		2.57%	4.42%	20.59%
4350	76 Outperform	¥13.79B	10.58		2.62%	6.09%	-30.07%
9265	76 Outperform	¥6.79B	11.01		2.29%	3.06%	-6.60%
2689	72 Outperform	¥12.86B	9.49		3.79%	3.95%	-11.14%
3183	70 Outperform	¥37.32B	18.45		4.00%	11.04%	20.33%
3151	68 Neutral	¥54.62B	8.15		3.96%	2.19%	30.44%
Sector *	54 Neutral	$5.34B	3.27	-45.10%	3.30%	16.80%	0.02%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA HEALTHCARE Reports Modest Sales Growth Amid Profit Decline

OLBA HEALTHCARE HOLDINGS, Inc. reported a modest increase in net sales for the nine months ending March 31, 2025, despite a decline in operating and ordinary profits compared to the previous year. The company’s financial position shows a slight increase in total assets and net assets, although the equity ratio decreased. The announcement indicates a stable dividend forecast, with no revisions to the financial results forecast, suggesting a cautious but steady approach to growth and shareholder returns.